Search

everythinglearnresearchcommunity

for

Search:↓

Nourella® effectively improves skin thickness and elasticity, reversing aging signs.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Genital rejuvenation is becoming popular for improving genital appearance and function in both men and women.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

ERULUS is crucial for root hair growth by controlling calcium levels.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

QLT0267 stops hair follicle cell growth and movement.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

The treatment cleared psoriasis in some patients but caused side effects in most.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.